Introduction The International Council for Harmonisation (ICH) emerged in 1990 as a collaborative effort between regulatory bodies and the pharmaceutical industry from the United States, Europe, and J...
<h2 id="introduction">Introduction</h2> <p>The International Council for Harmonisation (ICH) emerged in 1990 as a collaborative effort between regulatory bodies and the pharmaceutical industry from the United States, Europe, and Japan. The aim was to streamline regulatory requirements and technical standards for the development and registration of pharmaceutical products. By harmonizing guidelines, ICH facilitates a more predictable regulatory environment, enabling pharmaceutical companies to navigate the drug development process more efficiently and bring life-saving medications to patients sooner.</p> <p>In addition to fostering international cooperation, the ICH delves into the granular aspects of pharmaceutical development and registration, providing a systemic approach to assessing the potential for drug interactions and ensuring the safety and efficacy of medications. Recent developments, such as the ICH M14 initiative and the increasing a…